A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects

NCT03586076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

BIOLOGICAL: JHL1922
BIOLOGICAL: dornase alfa

Sponsor

JHL Biotech, Inc.